Microbiotica has completed patient recruitment for its phase 1b trial, COMPOSER-1, evaluating MB310 in adults with ulcerative ...

AbbVie is ending development of an IL-1 asset as a monotherapy in ulcerative colitis (UC) after a phase 2 study revealed ...

Announces positive data for rosnilimab, a pathogenic T cell depleter, through Week 38 from Phase 2b rheumatoid arthritis trialEnrollment completed for rosnilimab Phase 2 ulcerative colitis trial; ...

Researchers from The University of Osaka reveal that the intestinal flora works in combination with the mutated OTUD3 gene ...

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live ...

Results from the Phase III ABTECT-1 (NCT05507203) and ABTECT-2 (NCT05507216) trials showed that Abivax’s obefazimod demonstrated significant clinical remission in patients with ulcerative colitis.

Learn about toxic megacolon, a serious complication of IBD. Discover its causes, symptoms, diagnosis, treatment, and ...

The interaction between a common gene variant and gut microbes may trigger chronic inflammation in ulcerative colitis, new research suggests.

Sara Levitt and her life-saving ostomy bag are front and centre at the 2025 Miss Universe Canada pageant. On Aug. 9, the ...

After a long, cash-strapped journey, French biotech Abivax has presented top-line data from the twin phase 3 trials of its lead ulcerative colitis candidate.  | After a long, cash-strapped journey, ...

Greater access to innovative treatments could be linked to a drop in patients requiring surgery for a type of inflammatory bowel disease, a 20-year study suggests.

While each person with ulcerative colitis has different dietary triggers, coffee and one of its main components, caffeine, are common culprits.